Quick Answer
Wave Life Sciences Ltd. reported Research And Development Expense of $182.78 million for the year ending 2025.
- Wave Life Sciences Ltd. showed an increase of +14.5% in Research And Development Expense from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $585.0 thousand | Q1 2015: $1.61 million | Q2 2015: $1.85 million | Q3 2015: $2.13 million | Q1 2016: $4.74 million | Q2 2016: $8.40 million | Q3 2016: $13.69 million | Q1 2017: $14.74 million | Q2 2017: $19.10 million | Q3 2017: $20.10 million | Q1 2018: $29.20 million | Q2 2018: $32.55 million | Q3 2018: $32.88 million | Q1 2019: $40.11 million | Q2 2019: $41.61 million | Q3 2019: $44.59 million | Q1 2020: $41.16 million | Q2 2020: $31.48 million | Q3 2020: $28.28 million | Q1 2021: $33.39 million | Q2 2021: $31.64 million | Q3 2021: $31.09 million | Q1 2022: $27.47 million | Q2 2022: $29.73 million | Q3 2022: $27.58 million | Q1 2023: $30.98 million | Q2 2023: $33.31 million | Q3 2023: $31.64 million | Q1 2024: $33.45 million | Q2 2024: $40.39 million | Q3 2024: $41.20 million | Q1 2025: $40.62 million | Q2 2025: $43.47 million | Q3 2025: $45.87 million.
- Over the full 13 years of available data (2013 to 2025), Wave Life Sciences Ltd.'s Research And Development Expense has grown by 9,419.7%.
- Historical annual values: Fiscal year 2025: $182.78 million | Fiscal year 2024: $159.68 million | Fiscal year 2023: $130.01 million | Fiscal year 2022: $115.86 million | Fiscal year 2021: $121.88 million | Fiscal year 2020: $130.94 million | Fiscal year 2019: $175.43 million | Fiscal year 2018: $134.43 million | Fiscal year 2017: $79.31 million | Fiscal year 2016: $40.82 million | Fiscal year 2015: $9.06 million | Fiscal year 2014: $2.40 million | Fiscal year 2013: $1.92 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: